TMVR: Early benefits, late questions

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Apr 2022 English Publisher:WileyJournal:Catheterization and Cardiovascular Interventions, volume 99, pages 1,666-1,667 (issn: 1522-1946, eissn: 1522-726X,

Copyright policy )

Authors: Marvin H. Eng; H. Kenith Fang;

doi: 10.1002/ccd.30208

pmid: 35476288

TMVR: Early benefits, late questions

- Summary
- Subjects
- Metrics

Abstract

Key Points Transcatheter mitral valve replacement (TMVR) appears to have better early survival compared to surgical mitral valve replacement (SMVR). Over the long‐term, TMVR has attenuated survival compared to SMVR and this attributed to advanced age, chronic lung disease, more advanced heart failure and pulmonary hypertension. Low rates of mortality for TMVR are likely linked to the iterative improvement in techniques to use transseptal access for implantation.

Related Organizations

Banner Health
United States
Banner Good Samaritan Medical Center
United States

Keywords

Treatment Outcome, Humans, Mitral Valve, Mitral Valve Insufficiency

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average